Delivery Order SPE2DB22D2206-SPE2DB25FGR38

Award Date 4/21/25
Potential Completion Date 5/12/25
Potential Value $7.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,458.82 firm fixed-price delivery order is for the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML, with a period of performance through July 16, 2025. The contract is not set-aside and was awarded on June 24, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,376.70 firm-fixed-price delivery order is for the supply of the medication ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract has an ultimate completion date of December 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,688.23 delivery order contract is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The contract has an ultimate completion date of March 17, 2025 and is a firm fixed price arrangement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,506.72 firm-fixed-price delivery order is for the supply of the medication ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract has an ultimate completion date of November 21, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,688.23 firm fixed-price delivery order is for the pharmaceutical product ENTYVIO 108 MG/0.68 ML PEN 0.68ML. The contract has an ultimate completion date of April 8, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,376.70 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the specialty medication ENTYVIO 108 MG/0.68 ML PEN 0.68ML, with a period of performance through November 2024. AmerisourceBergen, a for-profit organization, holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,917.64, is a delivery order for the product ENTYVIO 108 MG/0.68 ML PEN 0.68ML. It is a firm fixed-price contract with a completion date of June 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a specialty medication. The $2,376.70 firm fixed price contract has a completion date of November 14, 2024. This appears to be a delivery order against an existing Indefinite Delivery Contract (IDC) worth $999,999,999 that AmerisourceBergen holds with the DLA...
This is a $4,917.64 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the medication ENTYVIO 108 MG/0.68 ML PEN 0.68ML, with a period of performance through July 9, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,917.64 firm fixed price delivery order is for the supply of ENTYVIO 108 MG/0.68 ML PEN 0.68ML, a prescription medication. The contract has an ultimate completion date of July 25, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FGR38
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,376.46 firm fixed-price delivery order is for the medication ENTYVIO 108 MG/0.68 ML PEN 0.68ML, with a completion date of May 12, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard. The contract award is not designated as a set-aside.

Generated 7/21/25, 7:48 PM